OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 19 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $2,000 | – | 855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Wealth Advisors, Inc. | 93,953 | $135,000 | 0.03% |
| NWAM LLC | 24,000 | $34,000 | 0.01% |
| WADE G W & INC | 15,000 | $21,000 | 0.00% |
| Financial Architects, Inc | 6,100 | $9,000 | 0.00% |
| JANE STREET GROUP, LLC | 54,756 | $78,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,200 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,371 | $9,000 | 0.00% |
| UBS Group AG | 4,671 | $6,000 | 0.00% |
| CITIGROUP INC | 2,158 | $3,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 128,306 | $183,000 | 0.00% |